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Introduction
Heart rate variability (HRV) is a noninvasive electrocar-
diographic marker which reflects the sympathetic and para-
sympathetic influences on sinus node of the heart, and in 
this way can show the ability of the heart to adapt to differ-
ent physiological situations. HRV expresses the variations of 
heart rate and duration of RR intervals (intervals between 
QRS complexes on ECG) when depolarization in the heart 
is controlled by normal pacemaker. In other words, HRV 
analysis shows the baseline autonomic function of the heart 
[1,2,3]. In a healthy heart with normal sympathetic- para-
sympathetic influences on sinus pacemaker, there will be 
continuous changes of the sinus cycles. Normal HRV re-
flects a balanced sympathovagal state of the heart. Gender, 
age, circadian rhythm, respiratory rate and body position 
are physiological factors which may influence HRV [4,5,6]. 
Measurements of HRV are noninvasive, and highly repro-
ducible. They may be performed on the basis of 24 hour 
Holter recordings or on shorter periods ranging from 0.5 to 
5 minutes particularly in the field of dynamic electrocardi-
ography. Most Holter devices manufactured nowadays have 
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Abstract
 
Background: Administration of propofol and fentanyl for induction of general anesthesia is often associated with cardiovascular instability. This effect 
can be caused by changes in the cardiac autonomic tonus induced by the drugs. In the literature there is no consensus regarding the effect of propofol 
and fentanyl on sympathetic or parasympathetic balance of the heart. 
Material and methods: There was performed a randomized prospective study which was approved by the Ethic Committee. Written informed consent 
was signed by all patients. The study group involved 47 patients scheduled for surgical intervention, anesthetic risk ASA I-II. The analysis of heart rate 
variability and the changes in cardiac autonomic tonus was performed with Holter ECG at rest, after premedication with fentanyl solution and after 
induction of general anesthesia with propofol and fentanyl. 
Results: After administration of fentanyl in doses of 1.0 mkg/kg for premedication there were not significant changes of heart rate variability and autonomic 
heart tonus.  Administration of propofol 2.5 mg/kg combined with fentanyl 1.0 mkg/kg for induction of general anesthesia leads to significant changes in 
heart rate variability. There was a considerable reduction of heart rate variability. The LFun (marker of sympathetic heart tonus) has enhanced by 6.8% 
compared with previous stage (67.1 (95% CI 63.1-71.1) vs 72.0 (95% CI 67.9-76.1) (p=0.004).  The HFun (marker of parasympathetic cardiac tonus) has 
reduced by 19.8% (32.9 (95% CI 28.9-36.8) vs 26.4 (95% CI 20.4-34.3) (p=0.007). After administration of propofol and fentanyl for induction of general 
anesthesia the LFun/HFun ratio has enhanced by 30.8% (2.7 (95%CI 2.1-3.4) vs 3.9 (95%CI9 2.9-4.8) (p=0.003), signaling an enhanced sympathetic 
heart tonus.
Conclusions: Administration of fentanyl solution in doses 1.0 mkg/kg for premedication is not associated with significant changes of autonomic tonus 
of the heart. Administration of propofol 2.5 mg/kg in combination with fentanyl 1.0 mkg/kg for induction of general anesthesia leads to significant 
enhanced sympathetic cardiac tonus. 
Key words: heart rate variability, sympathetic cardiac tonus, parasympathetic cardiac tonus.
HRV analysis programs which are incorporated into their 
instrument systems [7,8]. Most studies in anesthesia and 
intensive care which used the HRV for analysis of changes 
in sympathetic-parasympathetic balance of the heart per-
formed the 5 minutes analysis of HRV [9-15].
In 1996 a Task Force of the European Society of Car-
diology (ESC) and the North American Society of Pacing 
and Electrophysiology (NASPE) defined and established 
standards of measurement, physiological interpretation and 
clinical use of HRV. Time domain indices, geometric mea-
sures and frequency domain indices constitute nowadays 
the standard clinically used parameters [16].
Heart rate variability has been used in different clinical 
settings, including diabetes, arterial hypertension, coronary 
artery disease, sudden cardiac death, and for the screening 
of patients with obstructive sleep apnea. Furthermore, the 
effects of a variety of pharmacological and non-pharmaco-
logical interventions on HRV have been studied, such as an-
tiarrhythmic drugs, physical effort and after radiofrequency 
ablation procedures [2.9]. In the field of Anesthesiology and 
Intensive Care, HRV analysis was used for assessment of se-
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dation and analgesia, risk for development of hypotension 
after spinal or epidural anesthesia, for assessment of vegeta-
tive effects of different hypnotic drugs used in general anes-
thesia [2,14,15,17,18].
General anesthesia is usually associated with changes in 
sympathetic activity that may be due to mechanical venti-
lation, specific anesthetic drugs effects, the direct circula-
tory effects they induce, and/or their effects on central or 
peripheral nervous system. Most anesthetics used nowa-
days interfere with sympathetic neural outflow and cardio-
vascular regulation [19-22]. Propofol is a frequently used 
hypnotic for induction of general anesthesia but it can in-
duce hypotension, particularly when injected rapidly. Many 
mechanisms have been involved for explanation of propofol 
induced arterial hypotension, mainly direct depression of 
myocardium, reduced peripheral vascular resistance caused 
by direct vasodilatory effect of the drug, reduction of pre-
load and afterload. The studies anyway, showed controver-
sial results, and any of these factors could be imputed for 
hemodynamic instability after administration of propofol 
for sedation or for induction of general anesthesia. The ob-
served decrease of peripheral vascular resistance in patients 
with artificial hearts points to a direct vasodilatating effect 
of propofol or a decrease in sympathetic vasoconstrictor ac-
tivity. On the other hand, when propofol was infused in the 
brachial artery vasodilatation did not occur. Accordingly, 
other mechanisms must be responsible for the observed va-
sodilatation during propofol anesthesia [20,23,24].
Most published studies regarding the effects of propo-
fol or fentanyl on heart autonomic tonus were performed 
with sedative doses of drugs. Administration of propofol for 
moderate or deep sedation is frequently associated with a 
significant decrease in mean blood pressure. This hypoten-
sive effect of the drug can be caused by reduction of sympa-
thetic cardiac tonus or disturbances in baroreceptor-media-
ted cardiac activity [20,25,26,27].
The purpose of this clinical research was to find changes 
in sympathetic and parasympathetic heart tonus by analy-
zing HRV after administration of propofol in combination 
with fentanyl for induction of general anesthesia.
Material and methods
We performed a prospective randomized study to evalu-
ate the changes of vegetative heart tonus after induction of 
general anesthesia with fentanyl and propofol. The protocol 
of the study was approved by the Ethic Committee of Nico-
lae Testemitsanu State University of Medicine and Pharma-
cy, No 20 of 02.02.2016. 
Between March 2017 and September 2017, ASA physi-
cal status I-II patients scheduled for elective surgical proce-
dures aged under 60 years (to exclude age-related changes 
of HRV), and with normal sinus rhythm on ECG were 
enrolled in the study. We obtained an informed consent 
from all participants in the study. Patients with diseases 
that could interfere with vegetative heart tonus (endocrine, 
neurological, cardiovascular diseases) were excluded from 
the study. Another exclusion criterion was the presence of 
more than 20% of artifacts on ECG trace. 
In the operating room, the patients were monitored with 
electrocardiogram (ECG), non-invasive blood pressure, 
pulse oximetry and capnography. Baseline heart rate, blood 
pressure and respiratory rate were recorded. During induc-
tion of general anesthesia, oxygen was delivered to ensure a 
SpO2 above 95%. The patients received 10 ml/kg crystalloid 
intravenously before induction of anaesthesia.
We attached 10 electrodes on the chest and abdomen of 
the patients and connected them to Holter monitor (Holter 
TLC 5000, USA) within 25-30 minutes after admission to 
surgical room. HRV parameters were analyzed at rest (base-
line), after premedication with fentanyl 1.0 mkg/kg and af-
ter induction of general anesthesia with propofol 2.5 mg/
kg and fentanyl 1.0 mkg/kg (fig. 1). The dose of propofol 
and fentanyl was given over 30 s, until a loss of conscious-
ness, while the patient was breathing 100% oxygen. The loss 
of consciousness was defined as a loss of the eyelash reflex 
and no reaction to subsequent positive-pressure mask ven-
tilation. After administration of propofol and fentanyl and 
development of bradypnea or apnea, the mask ventilation 
was initiated in order to ensure a frequency of ventilation of 
14-16/min and a tidal volume 7-8 ml/kg, an important re-
quirement for correct registration and analysis of HRV and 
interpretation of sympathetic-parasympathetic heart tonus.
HRV parameters and changes in sympathetic and para-
sympathetic vegetative heart tonus were analyzed by Holter 
computerized system. Parameters of HRV and their signifi-
cance are presented in table 1 and were interpreted accor-
ding to the recommendations of the Task Force of the Euro-
pean Society of Cardiology and the North American Society 
of Pacing and Electrophysiology [16].
Statistical analysis of the results was done in accordance 
with the statistical program GraphPad Prism 6 (GraphPad 
Software, San Diego, California, USA). Values of parametric 
distribution were analyzed by t-pair and repeated measures 
of ANOVA tests. Values of non-parametric distribution 
were analyzed by Wilcoxon and Friedman tests. Results are 
presented in the form of average and 95% confidence in-
terval (for parametric data) and median with interquartile 
range (IQR – for non-parametric data). Value of p<0.05 was 
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Fig. 1.  Flow chart showing the study protocol.
21
22
I. Feghiui et al. Moldovan Medical Journal. June 2019;62(2);20-25 ORIGINAL  ReseARch
considered statistically significant.  The number of patients 
involved in the study group was determined in order to en-
sure a study power of 80%, α-error of 5% at a detectable dif-
ference of heart tonus between stages of at least 0.5. As well, 
there was considered a proportion of 10% of patients that 
couldn’t be involved in final analysis for different reasons. 
Such study group involved 47 patients.
Table 1
Parameters of HRV analyzed by ECG Holte
Parameters of HRV Significance Reference values
TP – Total spectral 
power of HRV  (ms2)
All vegetative influen-
ces on the heart 
(sympathetic, parasym-
pathetic, influences 
from peripheral and 
central chemoreceptors, 
baroreceptors)
3466.0±1018.0
Normalized spectral 
power of low frequency 
(LFun – Low Frequency)
Sympathetic and baro-
receptor influences on 
the heart
54.0 ±4.0
Normalized spectral 
power of high frequency 
(HFun – High Frequency)
Parasympathetic inf-
luences on the heart
29.0 ±3.0
LFun/HFun ratio Sympathetic-parasym-
pathetic heart balance
1.5-2.0
Interpretation and normal ranges are presented accord-
ing to the recommendations of the Task Force of the Euro-
pean Society of Cardiology and the North American Society 
of Pacing and Electrophysiology [16].
Results
The group of patients who benefited from the induction 
of general anesthesia with propofol and fentanyl comprised 
47 patients (26 females and 21 males) at the age of 37.5±11.9 
years. Body mass index varied from 16.1 kg/m2 to 30.0 kg/
m2 with the average 24.6±3.4 kg/m2. Most patients in the 
group benefited from the induction of general anesthesia 
with fentanyl and propofol for laparoscopic cholecystecto-
my (24 cases – 51.1%), followed by 7 patients with mandible 
osteosynthesis (14.9%), 4 cases for discectomy (8.5%), 2 
cases for syaloadenectomy (4.2%), 2 patients for excision of 
maxilar cyst (4.2%), 2 cases for scar excision and lip remod-
eling (4.2%). The other six cases (12.8%) were for different 
surgical procedures (maxillary osteoplastia, plastia of fron-
tal bone, removal of metallic blade from the arm, resection 
of cervical cyst, remodeling of ears, and reposition of nasal 
bones). All patients involved in the study were with minimal 
anesthetic risk (ASA I-II).
After administration of fentanyl solution for premedi-
cation purposes there were no attested significant changes 
of HRV parameters when compared with baseline values 
(tab. 2). Total spectral power of HRV has reduced by 12.6% 
compared with baseline (1400.0 ms2 (CI 95%1069.0-1731.0) 
vs 1223.0 ms2 (CI 95% 949.4-1496.0), (p=0.2). The LFun – 
marker of sympathetic cardiac tonus – has increased by 0.4% 
(66.8 (CI 62.6-70.9) vs 67.1 (CI 95% 63.1-71.1), (p=0.8). On 
the other hand, HFun – marker of parasympathetic cardiac 
tonus – has reduced, although this reduction is statistically 
insignificant compared with baseline value. The spectral 
power of HFun has reduced by 0.9% (33.2 (95% CI 29.0-
37.4) vs 32.9 (95% CI 28.9-36.8), (p=0.8), (fig. 2). The LFun/
HFun ratio didn’t change significantly and was 2.7±0.3 both, 
in baseline and after administration of fentanyl for premedi-
cation (fig. 3). So, after administration of fentanyl 1.0 mkg/
kg for premedication there were not attested significant 
changes in autonomic heart tonus, and the HRV parameters 
show the presence of enhanced sympathetic tonus of the 
heart in patients involved in the study.
Significant changes of HRV were attested after admin-
istration of propofol 2.5 mg/kg and fentanyl 1.0 mkg/kg 
for the induction of general anesthesia (tab. 3). The total 
spectral power of HRV has reduced by 70.4% (1223.0 ms2 
(95% CI 949.4-1496.0) vs 362.1ms2 (95% CI 257.3-466.9), 
(p=0.0001). There was noted a significant reduction of spec-
tral power of HFun – marker of heart parasympathetic veg-
etative tonus. The spectral power of HFun has reduced by 
19.8% (32.9 (95% CI 28.9-36.8) vs 26.4 (95% CI 20.4-34.3), 
(p=0.007). The reduction of the power of HFun is a proof 
of the cardiac vagolitic effect of propofol given in doses for 
the induction of general anesthesia. On the other hand, 
there was registered enhanced spectral power of LFun, such 
marking an enhanced sympathetic heart tonus and barore-
ceptor influences on the sinus node of the heart. The spec-
tral power of LFun has enhanced by 6.8% compared with 
previous stage (T2) (67.1 (95% CI 63.1-71.1) vs 72.0 (95% 
CI 67.9-76.1), (p=0.004), (fig. 2). The ratio LFun/HFun has 
enhanced by 30.8% (2.7 (95%CI 2.1-3.4) vs 3.9 (95%CI9 
2.9-4.8), (p=0.003) after administration of fentanyl and pro-
pofol (fig. 3). Both, significantly enhanced LFun and LFun/
HFun ratio in patient who received propofol 2.5 mg/kg and 
fentanyl 1.0 mkg/kg for the induction of general anesthesia 
proved the presence of enhanced sympathetic heart tonus 
and the cardiac sympathomimetic effects of propofol.
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Fig. 2.  Changes of LFun and HFun during anesthesia induction 
with propofol and fentanyl (*p<0.05).  Values are presented as 
mean with 95% confidence intervals (error bars).
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Fig. 3.  Changes of sympathetic-parasympathetic heart tonus 
during general anesthesia induction with propofol and fentanyl 
(*p<0.05).  Values are presented as mean with 95% confidence 
intervals (error bars).
Table 2
Changes of HRV parameters at rest,  
after premedication and induction of general  
anesthesia with propofol and fentanyl  
(Repeated measures ANOVA and Friedman’s test*)
HRV pa-
rameters
T1 T2 T3 p
TP (ms2) * 1400.0
(1069.0-1731.0)
1223.0
(949.4-1496.0)
362.1
(257.3-466.9)
0.0001
LFun 66.8
(62.6-70.9)
67.1
(63.1-71.1)
72.0
(67.9-76.1)
0.09
HFun 33.2
(29.0-37.4)
32.9
(28.9-36.8)
26.4
(20.4-34.3)
0.04
LFun/
HFun 
2.7
(2.1-3.2)
2.7
(2.1-3.4)
3.9
(2.9-4.8)
0.02
*Values are presented as mean and 95% confidence interval for parameters 
with normal distribution and median with intercvartilic range for values 
with non-parametric distribution.
If in baseline, 38.3% of patients presented enhanced 
sympathetic cardiac tonus, 38.3% – enhanced parasympa-
thetic cardiac tonus and 23.4% – cardiac eutonia, after ad-
ministration of fentanyl 1.0 mkg/kg for premedication there 
was detected an enhanced proportion of patients with in-
creased sympathetic tonus of the heart (42.5%). The rate of 
patients with enhanced parasympathetic heart tonus didn’t 
change and was attested in 18 patients (38.3%), exactly as in 
baseline.  Meantime, the rate of patients with cardiac euto-
nia has decreased to 19.1%. After administration of propo-
fol 2.5 mg/kg and fentanyl 1.0 mkg/kg for the induction of 
general anesthesia there was attested a significant increase 
in the proportion of patients with enhanced sympathetic to-
nus of the heart (51.1%) and reduction in the proportion of 
patients with enhanced parasympathetic tonus of the heart 
(27.7%), (fig. 4).
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Fig. 4.  Structure of the group in function of autonomic heart 
tonus at rest, after premedication and induction of general 
anesthesia with propofol and fentanyl.
Discussion
Many factors control perfusion in the peripheral tissues. 
From these should be mentioned cardiac output, fraction of 
ejection, stroke volume, microcirculation and vascular tone. 
Most of these factors are modulated by the autonomic ner-
vous system. Disturbances in cardiac autonomic tonus can 
lead to adverse cardiovascular events. For anesthesiologists 
these aspects can be important during perioperative peri-
od, especially during the induction of anaesthesia, patient’s 
positioning, episodes of blood loss and surgical stimula-
tion, when cardiovascular instability can be life threatening 
[9,11,12].
HRV has gained importance in recent years as a tech-
nique employed to explore the autonomic nervous system. 
This method is widely used for studying physiology of ar-
rhythmogenesis [1,6]. Frequency domain (power spectral 
density) analysis describes the periodic oscillations of the 
heart rate signal decomposed at different frequencies and 
amplitudes, and provides information on the amount of 
their relative intensity (termed variance or power) in the 
heart’s sinus rhythm [2,16]. The HRV analysis may quanti-
tatively and rapidly appreciate the balance of cardiac sym-
pathetic and parasympathetic activities, as well as their ef-
fects on cardiovascular system. This method is also useful 
for evaluation of changes in autonomic cardiac tonus after 
administration of anesthetic drugs in anesthesia [2,9].
The interpretation of HRV (LF, HF, LF⁄HF ratio) is to 
some degree still controversial. Nevertheless, interpreta-
tion of HF is more certain than that of LF. Based on many 
studies it is considered that LF reflects (at least in part) the 
sympathetic activity of the autonomic nervous system. An-
other parameter of HRV is HF which reflects the cardiac 
parasympathetic activity, and the LFun/HFun ratio which 
reflects the sympathetic/parasympathetic influences on the 
heart [16,28,29].
Propofol is a hypnotic agent widely used in anesthesia 
because of its favorable recovery profile and low incidence 
of side effects. However, induction of general anesthesia 
with propofol is often associated with a significant decrease 
in arterial blood pressure and heart rate. The hypotensive ef-
fect of propofol has been attributed to many factors. Mostly, 
reduction in arterial pressure after administration of propo-
fol is caused by low systemic vascular resistance or cardiac 
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output, impaired baroreflex mechanisms, and depression of 
myocardial contractility. Inhibition of the sympathetic ner-
vous system and reduced sympathetic cardiac tonus may 
explain all propofol-induced hemodynamic changes during 
anesthesia and was proposed as a mechanism of hypoten-
sive effect of the drug, but the precise mechanism by which 
this may occur is still unknown [20,23,26]. Although there 
is general agreement that induction of anesthesia with pro-
pofol is associated with a reduction in HRV, there are some 
conflicting data regarding the effects of propofol on cardiac 
sympathetic or parasympathetic tone [25-33].
The present study aimed to investigate the changes in the 
HRV in patients with minimal anesthetic risk undergoing 
the induction of general anesthesia with a combination of 
propofol and fentanyl.
In the literature there are studies which analyzed the 
changes in cardiac autonomic tonus during general anesthe-
sia with propofol but it is difficult to compare the results be-
tween them due to different anesthesia management, doses 
and combination of drugs, respiratory pattern, and method 
for HRV assessment. More than that, it was confirmed by 
some studies that the changes in sympathetic-parasympa-
thetic cardiac balance are different when there is adminis-
tration of drug in sedative doses or doses for the induction 
of general anesthesia [27-31].
In our study administration of fentanyl 1.0 mkg/kg for 
premedication didn’t change significantly the HRV param-
eters when compared to baseline values. In both time points 
(T1 and T2) the LFun/HFun ratio showed an enhanced 
sympathetic tonus of the heart. The values of LFun and 
HFun after fentanyl administration didn’t change signifi-
cantly in our study. A representative study that examined 
the cardiac vegetative effects of fentanyl by analysis of HRV 
is the study conducted and published by Vettorello M. et 
al. [22]. HRV as a measure of sympathovagal balance was 
prospectively analyzed in 11 subjects during spontaneous 
and paced breathing at 20 breaths/min both before and af-
ter fentanyl 1.0 mkg/kg administration. Conclusion of this 
study was that low-dose fentanyl administration in healthy 
volunteers decreases sympathetic cardiac tonus with a trend 
toward vagal activation of the heart. Anyway, the number 
of subjects involved is too small for a relevant conclusion. 
In another study, fentanyl was administered intravenously 
for premedication in doses of 3.0 mkg/kg. The analysis of 
HRV showed that HRV and LFun decreased, but not HFun, 
indicating a greater reduction of cardiac sympathetic activ-
ity [30]. To compare these results with our study is difficult 
as the doses of fentanyl given for premedication in our re-
search are twice smaller. But, the general conclusion is that 
fentanyl tends to enhance parasympathetic cardiac tonus 
and decrease the sympathetic one.
Most studies which analyzed the cardiac vegetative 
changes after administration of propofol for sedation pur-
poses show also conflicting results. Tarvainen M. et al. 
analyzed changes of autonomic cardiac tonus in 9 healthy 
males, at the age of 18-29 years. In this study, propofol was 
given intravenously using target control infusion aiming at 
pseudo steady-state plasma concentrations at 10 min inter-
vals starting from 1.0 μg/ml and followed by 0.25-0.5 μg/ml 
increases until loss of consciousness was reached. The results 
showed that there is an overall increase in HRV and espe-
cially in HF component [24]. So, propofol in small doses has 
a vagotonic effect on the heart. In another research authors 
studied the difference in the effects of midazolam and pro-
pofol on the cardiac nervous system during combined spi-
nal and epidural anesthesia. The study showed that propofol 
given in sedative doses during combined spinal epidural 
anesthesia produced little changes in LF and HF, and such 
doses do not influence the cardiac vegetative balance [27]. 
In a study conducted by Tsugayasu R. et al. propofol was 
infused using a target controlled infusion pump at an initial 
target effect-site concentration of 0.7g/mL [25]. The final re-
sult and conclusion in this study are similar to ours as in the 
same way after administration of propofol LFun/HFun ratio 
enhanced thus showing an increased sympathetic cardiac 
tonus. Exactly as in our study, the LFun increased and HFun 
decreased proving the vagolitic effect of propofol. As only 7 
subjects were enrolled in the study, the validity of the results 
obtained could be limited. Win N. et al. studied the effect of 
propofol sedation on vegetative cardiac balance by analysis 
of HRV in 30 dental implantation patients (ASA I physical 
status, age 30-62). Propofol was infused at an initial target 
effect-site concentration of 1 g/ml. The results of this study 
demonstrated that intravenous conscious sedations with 
propofol induced significantly decreases in TP, LF, HF and 
LFun/HFun ratio, indicating predominance of parasympa-
thetic activity during sedation [26]. So, most studies which 
used propofol in sedative doses showed the predominant 
vagotonic effect of it on the heart. These results are differ-
ent from our results, but in our study the dose of propofol 
administered for the induction of general anesthesia was 
higher and it was combined with fentanyl.
One representative study which examined the changes 
in cardiac balance by analysis of HRV after administration 
of propofol for the induction of general anesthesia was pub-
lished in 2017 [23]. In this prospective observational study, 
consecutive adult patients undergoing surgeries for supra-
tentorial tumour (study group) and brachial plexus injury 
(control group) were recruited. Electrocardiogram was re-
corded for 5 min at three time points – before propofol in-
duction, at propofol concentration of 2.0μg/ml and at pro-
pofol concentration of 4.0 g/ml. We will compare the results 
obtained in the control group. In brachial plexus group the 
sympathovagal balance, assessed by LFun/HFun ratio sig-
nificantly increased at propofol concentration of 4μg/ml and 
was due to low HF power. Total power of HRV decreased at 
4μg/ml. These results are similar to our findings as in our 
study administration of propofol reduces total power of 
HRV more than by 70% and the HFun reduced by 19.8%, 
thus proving the vagolitic effect of propofol. Riznyk L. et al. 
in a research on one hundred patients proved the fact that 
fentanyl-based induction of general anesthesia with propo-
fol increases the ratio of LFun/HFun [30]. Their results sug-
gest that induction of anesthesia with propofol reduces the 
cardiac parasympathetic tone more than sympathetic tone. 
This result is similar to that obtained in our research, even if 
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the doses of fentanyl were higher. Three other studies proved 
these results [31-33]. Kanaya N. et al. [31] and Hamada Y. 
et al. [32] using a maximum-entropy method for HRV as-
sessment, confirmed that anesthesia with propofol caused 
reduction in HFun power but not in LFun power, indicating 
that induction of anesthesia with propofol might reduce a 
cardiac parasympathetic tone more than sympathetic tone. 
In another study forty patients were randomly allocated to 
the propofol group and the midazolam-propofol group co-
induction. Propofol was administered at 2.5 mg/kg in the 
propofol group. The result revealed a greater decrease of the 
HFun as compared with that of the LFun in both groups, 
resulting in an increase of the LFun ⁄HFun ratio.
Our report showed that HRV analysis is a noninvasive 
method that is applicable to the assessment of changes in 
sympathovagal regulation that are associated with hemody-
namic changes during the induction of general anesthesia. 
Our findings imply that administration of propofol and fen-
tanyl for the induction of general anesthesia enhances the 
dominance of sympathetic nervous system on the heart. This 
finding should be considered during general anesthesia, es-
pecially in patients at risk of cardiovascular complications.
Conclusions
Administration of fentanyl 1.0 mkg/kg for premedica-
tion during general anesthesia is not associated with signifi-
cant changes in the autonomic cardiac tonus. 
Administration of propofol 2.5 mg/kg and fentanyl 1.0 
mkg/kg for the induction of general anesthesia is associated 
with a significant enhancement of sympathetic cardiac to-
nus and reduction of vagal influences on the heart.
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